Recombinant factor VIIa is associated with an improved 24-hour survival without an improvement in inpatient survival in massively transfused civilian trauma patients . Clinics [Internet]. 2011 Jan. 1 [cited 2024 May 16];66(1):101-6. Available from: https://www.revistas.usp.br/clinics/article/view/19460